Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0001193125-26-216704

Chief Medical Officer sold 70,003 shares at an average $38.36 ($2,685,515)

  • Chief Medical Officer acquired 70,003 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoulay Salomon · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-08 Exercise or conversion : show line 1 in the form 10b5-1 +55,000 $10.46 $575,300 69,769 D
2026-05-08 Sale : show line 2 in the form 10b5-1 −55,000 $38.38 $2,110,900 14,769 D
2026-05-08 Exercise or conversion : show line 3 in the form 10b5-1 +15,003 $16.00 $240,048 29,772 D
2026-05-08 Sale : show line 4 in the form 10b5-1 −15,003 $38.30 $574,615 14,769 D
Open-market sales · 70,003 sh · avg $38.36 · $2,685,515

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-08 Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) +55,000 194,540 D
2026-05-08 Exercise or conversion : show line 6 in the form 10b5-1 Stock option (right to buy) +15,003 30,008 D
Loading xslF345X06/ownership.xml…